Cargando…
Borneol and Α-asarone as adjuvant agents for improving blood–brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors
Puerarin (PUE) and tetramethylpyrazine (TMP) are central nervous system (CNS) drugs used in cerebrovascular diseases. Poor brain–blood barrier (BBB) permeability limited their clinical application. Borneol and α-asarone have been proposed as an oral brain-targeting enhancer. In this study, we aimed...
Autores principales: | Wu, Jun-Yong, Li, Yong-Jiang, Yang, Le, Hu, Yi-Yun, Hu, Xiong-Bin, Tang, Tian-Tian, Wang, Jie-Min, Liu, Xin-Yi, Xiang, Da-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201807/ https://www.ncbi.nlm.nih.gov/pubmed/30338713 http://dx.doi.org/10.1080/10717544.2018.1516005 |
Ejemplares similares
-
Percutaneous absorption and brain distribution facilitation of borneol on tetramethylpyrazine in a microemulsion-based transdermal therapeutic system
por: Hu, Xiaoge, et al.
Publicado: (2019) -
Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies
por: Yi, Tao, et al.
Publicado: (2017) -
Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism
por: Chen, Zi-xian, et al.
Publicado: (2019) -
Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability
por: Zhang, Qun-Lin, et al.
Publicado: (2017) -
α-Asarone Attenuates Osteoclastogenesis and Prevents Against Oestrogen-Deficiency Induced Osteoporosis
por: Tian, Hao, et al.
Publicado: (2022)